Travere Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.58 billion, with shareholders equity totaling $22.58 million.
The company employs approximately 262 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Travere Therapeutics Inc. reported $651.03 million in revenue, generating net income of $-121.51 million.
Key financial metrics include a P/E ratio of -37.70, a price-to-book (P/B) ratio of 202.84, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker TVTX.